A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
M
M
Nakayama
K
K
Yamada
H
H
Nakano
Y
Y
Miura
S
S
Suzuki
H
H
Tuchida
S
S
Yoshida
D000328:Adult; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000097:blood*; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology*; D015363:Quinolones / Q000494:pharmacology*
D065092:Antidiuretic Hormone Receptor Antagonists; D010880:Piperidines; D015363:Quinolones; D001127:Arginine Vasopressin; C068644:OPC 21268